• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Empowerment Health

Dr. Tara Power

  • Home
  • Meet Dr. Tara Power
  • Assessments
  • FAQ
  • Publications

Publications

Power, T.E., Swartzman, L.C., & Robinson, J.W (2011). Cognitive-emotional decision making (CEDM): A framework of patient medical decision making. Patient Education and Counseling 83(2) 163-169.

Power, T.E., Robinson, J.W., Bridge, P., Bernier, F.P. & Gilchrist, D.M. (2011). Distress and Psychosocial Needs of a Heterogeneous High-Risk Familial Cancer Population. Journal of Genetic Counseling 20(3) 249-269

Hall, M.A., Barton, J.C., Adams, P.C., McLaren, C.E., Reiss, J.C., Castro, O., Ruggiero, A., Acton, R.T., Power, T.E. (2007). Genetic screening for iron overload: No evidence of discrimination at one year. Journal of Family Practice  56(10) 829-834

Power, T.E., Adams, P. C., Barton, J.C., Acton, R.A, Howe, E., Palla, S., Walker, A. P., Anderson, R, Harrison, B., Thomson, E. (2007). Psychosocial Impact of Genetic testing for Hemochromatosis in the HEIRS Study: A comparison of participants recruited in Canada and in the United States. Genetic Testing 11(1), 55-64

Power, T.E. & Robinson, J (2006).Genetic mutation-related cancers: Important psychosocial issues for the Canadian general medical practitioner. Canadian Family Physician 52(11), 1425-1431

Anderson, R., Wenzel, L., Walker, A.P., Ruggiero, A., Acton, R., Hall, M.A., Tucker, D., Thompson, E., Harrison, B., Howe III, E., Holup, J., Leiendecker-Foster, C., Power, T.E., Adams, P.C. (2006). Impact of Hemochromatosis Screening In Patients with Indeterminate Results: The HEIRS Study. Genetics In Medicine 8(11), 681-687

Power, T.E. & Robinson, J.W. (2006). Addressing the psychosocial, ethical and legal issues of genetic mutation –related cancers. Oncology Exchange 5, 18-29

Hall, M.A., McEwen, J.E., Barton, J.C., Walker, A.P., Howe, E.G., Reiss, J.A. Power, T.E., Ellis, S.D., Tucker, D.C., Harrison, B.W., McLaren, G.D., Ruggiero, A. and Thomson,, E.J. (2005). Concerns in the primary care population about genetic discrimination by insurers. Genetics in Medicine 7(5), 311-316.

Power. T.E. (2005). Supporting a friend with a BRCA1/2 mutation. A response to am HBOC member. Gene Scene, Hereditary Breast, and Ovarian Cancer Newsletter, December 2005.

Power. T.E. & Adams, P.C. (2004). Hemochromatosis patients as voluntary blood donors. Canadian Journal of Gastroenterology 18(6), 393-396

Power, T.E. & Swartzman, L.C. (2003). Emotional and Cognitive factors in the decision to undertake BRCA1/2 testing in a community sample of Jewish women of Ashkenazi descent. Medical Decision Making 23(7).

Power, T. E. & Adams, P.C. (2001). The Psychosocial impact of C282Y mutation testing for hemochromatosis. Journal of Genetic Testing 5(2), 107-111. 

Footer

Location

EmPOWERment Health
1 Commercial Street, Ste 338

Note: Waiting Room and Check-In is Suite 301.

Truro, Nova Scotia Canada
B2N 3H8

Contact

Dr. Tara Power
Ph: 1.902.897.1644
Fax: 1.902.897.9589
Email: Office@empowermenthealth.ca

Make an Appointment

If you are seeking an appointment for an assessment,  please call our office directly.

Ph: 1.902.897.1644

Copyright © 2025 · Websites with Danielle